LoginRegister
    Merck KGaA, Pfizer develop Bavencio immuno-drug to alleviate kidney cancerMerck KGaA, Pfizer develop Bavencio immuno-drug to alleviate kidney cancer
    Foamix Pharmaceutical acne drug meets Goal in late stage trialFoamix Pharmaceutical acne drug meets Goal in late stage trial
    Alcon, Eye Care Unit of Novartis picks Geneva over Texas for new HQAlcon, Eye Care Unit of Novartis picks Geneva over Texas for new HQ
    328 FDC Medicines banned over safety concern: Health Ministry Notification328 FDC Medicines banned over safety concern: Health Ministry Notification
    Sun Pharma: USFDA Scrutinizes Mohali plant in PunjabSun Pharma: USFDA Scrutinizes Mohali plant in Punjab
    J&J case: Health Ministry asks victims to approach central or state panelJ&J case: Health Ministry asks 'victims' to approach central or state panel
    Zydus Cadila gets tentative USFDA approval for diabetes drugZydus Cadila gets tentative USFDA approval for diabetes drug
    Glenmark Pharma gets Marketing Authorisation for generic version of COPD drug in GermanyGlenmark Pharma gets Marketing Authorisation for generic version of COPD drug in Germany
    Suprise Visit check by CDSCO finds banned Oxytocin in East DelhiSuprise Visit check by CDSCO finds banned Oxytocin in East Delhi
    Johnson and Johnson, Health Ministry to meet to Discuss compensation to faulty implant victimsJohnson and Johnson, Health Ministry to meet to Discuss compensation to faulty implant victims
    Sun Pharma to acquire shares of Israeli firm Tarsius Pharma for Rs 21 croreSun Pharma to acquire shares of Israeli firm Tarsius Pharma for Rs 21 crore
    Sun Pharma shares continue to fall following USFDA observations at Halol PlantSun Pharma shares continue to fall following USFDA observations at Halol Plant
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X